Cincinnati Financial Free cash flow decreased by 30.4% to $654.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 113.0%, from $307.00M to $654.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 12.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $559.00M | $598.00M | $460.00M | $194.00M | $553.00M | $662.00M | $628.00M | $246.00M | $571.00M | $648.00M | $569.00M | $346.00M | $737.00M | $906.00M | $638.00M | $307.00M | $737.00M | $1.11B | $939.00M | $654.00M |
| QoQ Change | — | +7.0% | -23.1% | -57.8% | +185.1% | +19.7% | -5.1% | -60.8% | +132.1% | +13.5% | -12.2% | -39.2% | +113.0% | +22.9% | -29.6% | -51.9% | +140.1% | +50.5% | -15.3% | -30.4% |
| YoY Change | — | — | — | — | -1.1% | +10.7% | +36.5% | +26.8% | +3.3% | -2.1% | -9.4% | +40.7% | +29.1% | +39.8% | +12.1% | -11.3% | +0.0% | +22.4% | +47.2% | +113.0% |